Transcranial Magnetic Stimulation for the Treatment of Cocaine Addiction: A Systematic Review

Otros/as autores/as

Institut Català de la Salut

[Torres-Castaño A] Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, Spain. Evaluation Unit of the Canary Islands Health Service (SESCS), 38019 El Rosario, Spain. The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS), 28071 Madrid, Spain. [Rivero-Santana A, Duarte-Díaz A, Toledo-Chávarri A, Ramos-García V] Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, Spain. Evaluation Unit of the Canary Islands Health Service (SESCS), 38019 El Rosario, Spain. [Perestelo-Pérez L] Evaluation Unit of the Canary Islands Health Service (SESCS), 38019 El Rosario, Spain. [Serrano-Pérez P] Grup de Recerca en Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2022-05-31T06:42:18Z

2022-05-31T06:42:18Z

2021-12



Resumen

Cocaine use disorder; Craving; Non-invasive brain stimulation


Trastorn per consum de cocaïna; Ànsia; Estimulació cerebral no invasiva


Trastorno por consumo de cocaína; Ansia; Estimulación cerebral no invasiva


Long-term cocaine use is associated with cognitive deficits and neuro-psychiatric pathologies. Repetitive transcranial magnetic stimulation (rTMS) is an emerging therapeutic strategy relating to changes in brain activity. It stimulates the prefrontal cortex and is involved in inhibitory cognitive control, decision making and care. This systematic review aims to evaluate and synthesize the evidence on the safety, effectiveness, and cost-effectiveness of rTMS for the treatment of cocaine addiction. A systematic review of the literature was carried out. The following electronic databases were consulted from inception to October 2020: MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Central Register of Controlled Trials and Web of Science. Randomised controlled trials, non-randomised controlled trials and case-series and full economic evaluations were included. Twelve studies were included. No identified study reported data on cost-effectiveness. Significant results of the efficacy of TMS have been observed in terms of the reduction of craving to consume and the number of doses consumed. No serious adverse effects have been observed. Despite the low quality of the studies, the first results were observed in terms of reduction of cocaine use and craving. In any case, this effect is considered moderate. Studies with larger sample sizes and longer follow-ups are required.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

MDPI

Documentos relacionados

Journal of Clinical Medicine;10(23)

https://doi.org/10.3390/jcm10235595

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)